Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Tumbarello

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Critical Care (London, England)|October 25, 2011
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization indexBrunella Posteraro, Gennaro De Pascale, Mario Tumbarello, et al.
Annals of Hematology|November 30, 2013
Relapsing bloodstream infections during treatment of acute leukemiaChiara Cattaneo, Francesca Antoniazzi, Mario Tumbarello, et al.
Infection and Drug Resistance|January 6, 2021
Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging DataDaniele Roberto Giacobbe, Eugenio Ciacco, Corrado Girmenia, et al.
Open Forum Infectious Diseases|June 7, 2017
Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical TrialsElizabeth L Alexander, Jeffery Loutit, Mario Tumbarello, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 24, 2020
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentationFederica Sorà, Patrizia Chiusolo, Luca Laurenti, et al.
Critical Care (London, England)|August 28, 2016
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic countryMatteo Bassetti, Elda Righi, Maddalena Peghin, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2007
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatmentMario Tumbarello, Maurizio Sanguinetti, Eva Montuori, et al.
Plos One|April 6, 2012
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospitalMario Tumbarello, Barbara Fiori, Enrico Maria Trecarichi, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2009
Factors associated with mortality in bacteremic patients with hematologic malignanciesMario Tumbarello, Teresa Spanu, Morena Caira, et al.
The New Microbiologica|May 3, 2024
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests"Francesca Panza, Francesco Saladini, Niccolò Bartolini, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Critical Care (London, England)|October 25, 2011
Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1→3)-β-D-glucan assay, Candida score, and colonization indexBrunella Posteraro, Gennaro De Pascale, Mario Tumbarello, et al.
Annals of Hematology|November 30, 2013
Relapsing bloodstream infections during treatment of acute leukemiaChiara Cattaneo, Francesca Antoniazzi, Mario Tumbarello, et al.
Infection and Drug Resistance|January 6, 2021
Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging DataDaniele Roberto Giacobbe, Eugenio Ciacco, Corrado Girmenia, et al.
Open Forum Infectious Diseases|June 7, 2017
Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical TrialsElizabeth L Alexander, Jeffery Loutit, Mario Tumbarello, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|August 24, 2020
SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentationFederica Sorà, Patrizia Chiusolo, Luca Laurenti, et al.
Critical Care (London, England)|August 28, 2016
Is first-line antimicrobial therapy still adequate to treat MRSA in the ICU? A report from a highly endemic countryMatteo Bassetti, Elda Righi, Maddalena Peghin, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2007
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatmentMario Tumbarello, Maurizio Sanguinetti, Eva Montuori, et al.
Plos One|April 6, 2012
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospitalMario Tumbarello, Barbara Fiori, Enrico Maria Trecarichi, et al.
Diagnostic Microbiology and Infectious Disease|April 7, 2009
Factors associated with mortality in bacteremic patients with hematologic malignanciesMario Tumbarello, Teresa Spanu, Morena Caira, et al.
The New Microbiologica|May 3, 2024
PRESTIGIO RING "a 59-year-old man with multidrug resistant HIV-1 infection failing a regimen including dolutegravir, rilpivirine, atazanavir/cobicistat: successful treatment tailoring based on genotypic and phenotypic resistance tests"Francesca Panza, Francesco Saladini, Niccolò Bartolini, et al.
Pageof 20